Literature DB >> 239062

Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement system.

D Bitter-Suermann, U Hadding, H U Schorlemmer, M Limbert, M Dierich, P Dukor.   

Abstract

A number of T-independent antigens and B cell mitogens were examined for their ability to activate C3 via the alternative pathway of the complement system. Loss of hemolytically active C3, generation of anaphylatoxin activity, and immunoelectrophoretic conversion of C3 and factor B, were checked in normal and C4-deficient guinea pig serum, and, in some cases, in normal human serum. As judged by their activity in these assays, 10 lipopolysaccharides of different origin and constitution, pneumococcus type III polysaccharide, levan, dinitrophenylated aminoethyl-dextran, dinitrophenylated (D-glutamic acid, D-lysin) copolymer, polymerized flagellin, and pokeweed mitogen were all capable of initiating the alternative pathway, but differed with respect to their potency, their relative activity in the presence or absence of C4, and their ability to inhibit C3-turnover at high concentrations. Polyvinylpyrrolidone of intermediate molecular weight (4 x 10(4) daltons) was only active if the most sensitive assay was used (anaphylatoxin generation). Other species of polyvinylpyrrolidone, depolymerized pneumococcal polysaccharide, aminoethyl-dextran, [D-glutamic acid, D-lysin] copolymer, phytohemagglutinin and concanavalin A failed to activate C3. C3-consumption by concanavalin A was due to nonspecific binding.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239062

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Effects of activated complement components on enzyme secretion by macrophages.

Authors:  H U Schorlemmer; A C Allison
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

2.  Interaction of pneumococcal antigens with complement in rats.

Authors:  J D Coonrod; S Jenkins
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

3.  Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.

Authors:  J K Spitznagel; K J Goodrum; D J Warejcka; J L Weaver; H L Miller; L Babcock
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

4.  Superiority of human complement for assaying bacterial lipopolysaccharides by their anticomplementary activity.

Authors:  J N Saddler; A C Wardlaw
Journal:  Experientia       Date:  1978-09-15

5.  Regulation of endotoxin-induced inhibition of macrophage migration by fresh serum.

Authors:  D H Heilman
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

6.  Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system.

Authors:  G Füst; L Bertók; S Juhász-Nagy
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

7.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

8.  Complement activation by aluminium and zirconium compounds.

Authors:  V D Ramanathan; P Badenoch-Jones; J L Turk
Journal:  Immunology       Date:  1979-08       Impact factor: 7.397

9.  The role of Fc and C3b receptors in phagocytosis by inflammatory polymorphonuclear leucocytes in man.

Authors:  J M Wilton; H H Renggli; T Lehner
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

10.  Antibody-independent complement activation by a subpopulation of mitogen-induced human T lymphoblasts.

Authors:  M J Martin; J Vega; C Gutiérrez
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.